Published by Coherent Market Insights
Posted on September 30, 2021
Particle therapy is an emerging area of external beam radiotherapy in which external beams of neutrons or other energetic particles are used to kill cancerous cells in the patient’s body. Multi ion particle therapy systems are capable of generating both proton and heavy ion in one accelerator, which helps the system offer flexible treatment according to various symptom of patients and tumor sites.
The most common cancer that can be treated by this method are leukemia, cervical cancer, prostate cancer, melanoma, and Hodgkin’s lymphoma. High prevalence of cancer is expected to propel growth of the particle therapy market. According to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.
Get a Sample Copy of the Particle Therapy market Report 2021 @
https://www.coherentmarketinsights.com/insight/request-sample/3574
Major Market Players Profiled in the Particle Therapy Market Report include: Ion Beam Applications, Provision Healthcare, Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., ProTom International, Inc., Advanced Oncotherapy Plc., Varian Medical Systems, Inc., Hitachi, Ltd., Danfysik A/S, Provision Healthcare, LLC, and IBA Worldwide.
In May 2019, Hitachi, Ltd. signed a contract with Himed Hospital Management (Xuzhou) Co., Ltd., China, to deliver particle therapy system with capability of irradiating both proton and heavy ion. One of the reasons why the use of particle therapy has increased so much is that it can now be done in a number of different ways. One method is through single-room systems, multiple-room systems, and even distributed-patient systems. In September 2020, Particle Therapy Interuniversity Centre Leuven in Belgium started offering advanced treatment planning system RayStation and next-generation oncology information system RayCare. Such developments aid in growth of the particle therapy market.
One of the main reasons why particle therapy has become so popular over the past few years has to do with its effectiveness. Particle therapy is able to kill cancer cells with only a small fraction of the energy needed to kill them with conventional treatment methods. The number of passes through the machine is also much higher than what is required for chemotherapy. The greatest advantage to this form of treatment is that it does not require a whole hospital or multiple rooms for its operation. Instead, several small rooms may be required in order to get the job done. Such advantages aid in growth of the particle therapy market.
Ask for PDF sample copy of the Particle Therapy market report @
https://www.coherentmarketinsights.com/insight/request-pdf/3574
Radiation exposure is a major drawback of particle therapy, which is expected to limit growth of the particle therapy market. However, R&D of novel medical devices with non-woven fabric style made of bioabsorbable material that protects healthy organs from radiation exposure during particle therapy is expected to offer lucrative growth opportunities for players in the particle therapy market.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Particle Therapy Market Size, Share, Outlook, and Analysis, 2019 – 2027 | Ion Beam Applications, Provision Healthcare, Mevion Medical Systems, Inc appeared first on Gatorledger.
Particle therapy is an emerging area of external beam radiotherapy in which external beams of neutrons or other energetic particles are used to kill cancerous cells in the patient’s body. Multi ion particle therapy systems are capable of generating both proton and heavy ion in one accelerator, which helps the system offer flexible treatment according to various symptom of patients and tumor sites.
The most common cancer that can be treated by this method are leukemia, cervical cancer, prostate cancer, melanoma, and Hodgkin’s lymphoma. High prevalence of cancer is expected to propel growth of the particle therapy market. According to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.
Get a Sample Copy of the Particle Therapy market Report 2021 @
https://www.coherentmarketinsights.com/insight/request-sample/3574
Major Market Players Profiled in the Particle Therapy Market Report include: Ion Beam Applications, Provision Healthcare, Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., ProTom International, Inc., Advanced Oncotherapy Plc., Varian Medical Systems, Inc., Hitachi, Ltd., Danfysik A/S, Provision Healthcare, LLC, and IBA Worldwide.
In May 2019, Hitachi, Ltd. signed a contract with Himed Hospital Management (Xuzhou) Co., Ltd., China, to deliver particle therapy system with capability of irradiating both proton and heavy ion. One of the reasons why the use of particle therapy has increased so much is that it can now be done in a number of different ways. One method is through single-room systems, multiple-room systems, and even distributed-patient systems. In September 2020, Particle Therapy Interuniversity Centre Leuven in Belgium started offering advanced treatment planning system RayStation and next-generation oncology information system RayCare. Such developments aid in growth of the particle therapy market.
One of the main reasons why particle therapy has become so popular over the past few years has to do with its effectiveness. Particle therapy is able to kill cancer cells with only a small fraction of the energy needed to kill them with conventional treatment methods. The number of passes through the machine is also much higher than what is required for chemotherapy. The greatest advantage to this form of treatment is that it does not require a whole hospital or multiple rooms for its operation. Instead, several small rooms may be required in order to get the job done. Such advantages aid in growth of the particle therapy market.
Ask for PDF sample copy of the Particle Therapy market report @
https://www.coherentmarketinsights.com/insight/request-pdf/3574
Radiation exposure is a major drawback of particle therapy, which is expected to limit growth of the particle therapy market. However, R&D of novel medical devices with non-woven fabric style made of bioabsorbable material that protects healthy organs from radiation exposure during particle therapy is expected to offer lucrative growth opportunities for players in the particle therapy market.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Particle Therapy Market Size, Share, Outlook, and Analysis, 2019 – 2027 | Ion Beam Applications, Provision Healthcare, Mevion Medical Systems, Inc appeared first on Gatorledger.
Explore more articles in the Research Reports category
